Acute Myocardial Infarctionin a Patient with Nephrotic Syndrome and Polycythemia: A Case Report
Main Article Content
Abstract
The modifiable risk factors for acute myocardial infarction (AMI) include hyperlipidemia, diabetes mellitus, smoking, high blood pressure, visceral obesity, lack of exercise, high risk food intake and psychological stress. In this report, we presented the young man with AMI who had the underlying nephrotic syndrome and polycythemia. He was a 25-year-old Thai patientpresenting with acute chest pain 3 hours before admission. The electrocardiogram showed the ST elevations at leads II, III, AVF and the T inversions at leads V1-V4 with sinus tachycardia. The CK-BM and troponin-I enzymes were > 600 ng/ml and > 80 ng/ml, respectively. His hemoglobin concentration was 18.3 g% while other blood tests were: albumin 2.6 g%, cholesterol 365 mg%, triglyceride 567 mg%, FBS 102 mg%, protein S24 %, beta2 glycoprotein IgM 72.31 U/ml, noJAK2 V617F mutation, serum erythropoietin 2.4 mIU/ml. The urine protein was 14,673 mg/day. The diagnosis of AMI in the young with unusual risk factors including nephrotic syndrome, polycythemia, protein S deficiency, the presence of anti beta2 glycoprotein IgM, and hyperlipidemia. He was immediately treated with thrombolytic therapy and the coronary angiography. The thrombotic occlusion was demonstrated at the mid portion of the left circumflex coronary artery and he was also treated with medicated stent, ASA, phlebotomy and plasma transfusion. He dramatically responded to therapy and the elevated ST segment became normal after the coronary intervention. The possible relationship between AMI and nephrotic syndrome and polycythemia was discussed.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined-a consensus document of The Joint European Society of Cardiology/ American College of Cardiology Committee for the redefinition of myocardial infarction. J Am CollCardiol 2000; 36: 959-69.
Reddy K, Khaliq A, Henning RJ. Recent advances in the diagnosis and treatment of acute myocardial infarction. World J Cardiol 2015; 7: 243-76. doi: 10.4330/wjc.v7.i5.243.
Anand SS, Islam SS, Rosengren A, Franzosi MG, Steyn K, Yusufali AH, et al. Risk factors for myocardial infarction in women and men: insights from the INTERHEART study. Eur Heart J 2008; 29: 932-40.
Weinberger I, Rotenberg Z, Fuchs J, Sagy A, Friedmann J, Agmon J. Myocardial infarction in young adults under 30 years: risk factors and clinical course. Clin Cardiol 1987; 10: 9-15.
Karabay CY, Kocabay G, Kalayc 1 A. Acute inferior myocardial infarction with nephrotic syndrome. Am J Emerg Med 2012; 30: 260.e1-3. doi: 10.1016 j. ajem. 2010.11.004.
Silva JM, Oliveira EA, Marino VS, Oliveira JS, Torres RM, Ribeiro AL, et al. Premature acute myocardial infarction in a child with nephrotic syndrome. Pediatr Nephrol 2002; 17: 169-72.
Bahbahani H, Aljenaee K, Bella A. Polycythemia vera presenting as acute myocardial infarction: An unusual presentation. J Saudi Heart Assoc 2015; 27: 57-60.
Adel G, Aoulia D, Amina Y, Aymen BA, Abdel- Hamid NM. Polycythemia vera and acute coronary syndromes: pathogenesis, risk factors and treatment. J Hematol Thromb Dis 2013; 1:107. doi: 10.4172/2329-8790.1000107
Kobayashi Y, Kobayashi Y, Hirohata A. Left main coronary thrombotic occlusion due to secondary polycythemia in a normal sinus of valsalva. J Invasive Cardiol 2013; 25: 421-2.
Kershenovich S, Modiano M, Ewy GA. Markedly decreased coronary blood flow in secondary polycythemia. Am Heart J 1992; 123: 521-3.
Salobir B, Sabovic M, Hojnik M, Cucnik S, Kveder T. Anti-beta 2-glycoprotein I antibodies of IgM class are linked to thrombotic disorders in young women without autoimmune disease. Immunobiol 2007; 212: 193-9.
Ogasawara N, Kijima Y, Ike S, Nakagawa Y, Takagi T, Hata T, et al. Hereditary protein s deficiency with a history of recurrent myocardial infarction. Circ J 2003; 67: 166-8.
Ardiles L, Mezzano S. Erythrocytosis associated to idiopathic membranous nephropathy. Rev Med Chil 1992; 120: 430-2.
Lim CS, Jung KH, Kim YS, Ahn C, Han JS, Kim S, et al. Secondary polycythemia associated with idiopathic membranous nephropathy. Am J Nephrol 2000; 20: 344-6.
Shehab T, Ismail W. Nephrotic syndrome as the initial presentation of polycythemia vera. Austin J Nephrol Hypertens 2015; 2(2): 1035.
Tefferi A, Thiele J, Orazi A, Kvasnicka HM, Barbui T, Hanson CA, et al. Proposals and rationale for revision of the WHO diagnostic criteria for primary polycythemia, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel. Blood 2007; 110: 1092-7.
Nishi S, Ubara Y, Utsunomiya Y, Okada K, Obata Y, Kai H, et al. Evidence-based Clinical Practice Guidelines for Nephrotic Syndrome 2014.